We are live on ! Find out more
IPHS

Innophos Holdings, Inc.
IPHS

Delisted

IPHS was delisted on the 6th of February, 2020.

192 hedge funds and large institutions have $933M invested in Innophos Holdings, Inc. in 2016 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 74 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more call options, than puts

Call options by funds: $1.78M | Put options by funds: $753K

100% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 19

35% more capital invested

Capital invested by funds: $691M → $933M (+$242M)

10% more funds holding

Funds holding: 175192 (+17)

22% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 74

Holders
192
Holders Change
+17
Holders Change %
+9.71%
% of All Funds
4.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
38
Increased
58
Reduced
74
Closed
19
Calls
$1.78M
Puts
$753K
Net Calls
+$1.03M
Net Calls Change
+$1.02M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
151
Paradigm Asset Management
New York
$199K -$4.86K -100 -3%
AIM
152
Acrospire Investment Management
Illinois
$183K +$170K +3,500 New
Ohio Public Employees Retirement System (OPERS)
153
Ohio Public Employees Retirement System (OPERS)
Ohio
$164K -$15K -309 -9%
Federated Hermes
154
Federated Hermes
Pennsylvania
$154K -$320K -6,595 -69%
BlackRock
155
BlackRock
New York
$131K -$35.6K -733 -23%
GHCM
156
Glen Harbor Capital Management
California
$130K +$121K +2,482 New
FMT
157
First Mercantile Trust
Tennessee
$111K -$10.3K -212 -9%
SOADOR
158
State of Alaska Department of Revenue
Alaska
$109K +$102K +2,100 New
MCIM
159
Meadow Creek Investment Management
Georgia
$107K +$99.3K +2,044 New
Barclays
160
Barclays
United Kingdom
$100K +$24.4K +502 +35%
VCM
161
Versant Capital Management
Arizona
$94K -$2.72K -56 -3%
EP
162
Elkfork Partners
Oregon
$84K +$78K +1,606 New
Parallax Volatility Advisers
163
Parallax Volatility Advisers
California
$74K +$68.8K +1,417 New
SIA
164
Sit Investment Associates
Minnesota
$67K -$17K -350 -22%
Envestnet Asset Management
165
Envestnet Asset Management
Illinois
$67K +$3.98K +82 +7%
TRCT
166
Tower Research Capital (TRC)
New York
$67K +$61.9K +1,275 New
LTFS
167
Ladenburg Thalmann Financial Services
Florida
$61K -$9.37K -193 -14%
TAM
168
Tyers Asset Management
Texas
$61K +$56.7K +1,168 New
HIM
169
Hillsdale Investment Management
Ontario, Canada
$60K -$539K -11,100 -91%
PG
170
PEAK6 Group
Illinois
$54K +$50.2K +1,033 New
RCM
171
Riverhead Capital Management
Delaware
$42K
LIA
172
LS Investment Advisors
Michigan
$36K
Zurich Cantonal Bank
173
Zurich Cantonal Bank
Switzerland
$36K
PCM
174
Prelude Capital Management
New York
$34K +$3.16K +65 +11%
Bank of Montreal
175
Bank of Montreal
Ontario, Canada
$32K +$49 +1 +0.2%

IPHS Hedge Fund Activity: Q4 2016 in Review

192 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Innophos Holdings, Inc. (IPHS) for Q4 2016, worth a combined $933M — up 35% from $691M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IPHS positions and 19 closed out — a net gain of 19 holders — while 58 added to existing stakes and 74 trimmed.

The largest buyer was Daruma Capital Management, opening a new position worth an estimated $33.7M. The largest seller was Victory Capital Management, exiting entirely with an estimated $17.7M sold.

  • 192 institutional investors held Innophos Holdings, Inc. (IPHS) as of Q4 2016, up from 175 in Q3 2016.
  • Funds reported $933M of Innophos Holdings, Inc. stock for Q4 2016, up 35% quarter-over-quarter.
  • 38 funds opened new Innophos Holdings, Inc. positions in Q4 2016 and 19 closed out, a net change of +19 holders.
  • The largest Innophos Holdings, Inc. buyer in Q4 2016 was Daruma Capital Management, an estimated $33.7M added.
  • The largest Innophos Holdings, Inc. seller in Q4 2016 was Victory Capital Management, an estimated $17.7M sold.

Based on aggregated 13F filings for Q4 2016.